Diabetes is accompanied by a marked reduction in patient’s quality of life (QOL) and leads to higher disability-adjusted life years than most diseases. Depression further deteriorates QOL and is associated with poor treatment outcomes and lowered glycemic control in diabetes. We analysed the QOL and depression among the people living with diabetes in Nepal.
We conducted a cross-sectional survey among a random sample of 157 diabetic patients visiting diabetes clinic at a major teaching hospital in Kathmandu, Nepal. We administered the Nepali version of WHO-BREF for face to face interviews to obtain data on QOL scores. The Nepali version of Patient Health Questionnaire-9was also used to record responses on depression items.
More than half of the respondents (54.1%) experienced depression with mean PHQ-9 score of 6.15 ± 5.01 on a scale of 0–27. On a scale of 0 to 100, highest QOL mean score was reported in social relationship domain (57.32 ± 11.83), followed by environment domain (54.71 ± 7.74), psychological health (53.25 ± 10.32) and physical health (50.74 ± 11.83). After adjusting for other covariates, urban residence decreased the physical health score by 4.74 (β = -4.74, 95% CI: -8.664,-0.821), social relationship domain score by 3.420 (β = -3.420, 95% CI: -6.433,-0.406) and the overall QOL by 2.773 (β = -2.773, 95% CI: -5.295,-0.252). Having diagnosed with diabetes since more than 10 years increased physical health by 5.184 score points (β = 5.184; 95% CI: 0.753, 9.615).Similarly, having severe depression decreased social relation domain score by 6.053 (β = -6.053, 95% CI:-11.169,-.936).
Having urban residence significantly decreased the physical health and social relation domain scores as well as the overall QOL scores. Similarly, having diagnosed since more than 10 years increased physical health domain score. Severe depression decreased social relationship domain score. Since depression affects QOL, we suggest early diagnosis and prompt treatment of depression in T2DM people as part of their routine primary care in Nepal.
Citation: Mishra SR, Sharma A, Bhandari PM, Bhochhibhoya S, Thapa K (2015) Depression and Health-Related Quality of Life among Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Nepal. PLoS ONE 10(11): e0141385. https://doi.org/10.1371/journal.pone.0141385
Editor: Massimo Ciccozzi, National Institute of Health, ITALY
Received: June 24, 2015; Accepted: October 6, 2015; Published: November 23, 2015
Copyright: © 2015 Mishra et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: Approval must be granted from "Institutional Review Committee" of Manmohan Memorial Institute of Health Sciences". Request for data acquisition can be sent to Research Officer at IRC, email@example.com.
Funding: The authors have no support or funding to report.
Competing interests: The authors have declared that no competing interests exist.
The increasing burden of diabetes among adults (aged 20–70 years) is a major public health concern globally .The number of people living with diabetes is estimated to rise from 135 million in 1995 to 300 million by 2025. Developing countries are expected to observe a 170% increase in prevalence of diabetes compared to 42% increase in developed countries. In 2025, over 75% of people with diabetes globally will be residing in developing countries .In particular the diabetes prevalence among Asian populations is increasing rapidly, driven largely by economic development, nutrition transition, and sedentary lifestyles. In 2007, around 110 million individuals were living with diabetes in Asia, with young and middle aged population being affected disproportionately .
Nepal, largely an agrarian country, has witnessed a rapid surge of diabetes cases in recent years. According to the World Health Organization (WHO) estimates, the cases of diabetes in Nepal are expected to increase from the 436,000 (2% prevalence) in 2000 to 1,328,000 (10% prevalence) in 2030 . Baral et al reported the prevalence of diabetes at 5.3% .There exists a rural-urban divide in diabetes prevalence: while 2.5% of the rural populations are living with diabetes, the prevalence is as high as 14.6% among the urban population . Kathmandu, the capital and largest metropolitan city in Nepal has diabetes prevalence of 25.9% .
Type 2 diabetes mellitus (T2DM) accounts for the majority of all diabetes cases. T2DM has a number of chronic effects, including disability, cardiovascular disease, kidney disease, and blindness .T2DM is also accompanied by marked reduction in the quality of life (QOL) . Comorbid depression further reduces QOL in people with T2DM , and is associated with poor treatment outcomes and lowered glycemic control [10, 11]. Prevalence of depression is twofold in people with T2DM compared to those without . In Nepal, the prevalence of depression among people living with diabetes (40.3%) is more than twice the global prevalence of 17.6% [10–11]. This suggests that people with T2DM in Nepal may have relatively lower QOL. While several studies have addressed the issue of QOL among diabetes patients [8, 13–16] across different cultural settings globally, a little is known about the QOL among the T2DM patients in Nepal. Understanding which QOL domains are associated with depression among patients with diabetes in Nepal will be useful for better diabetes management in clinical settings. To that end, we analyzed the QOL scores among people with T2DM in Nepal. This study was conducted prior to the unfortunate Nepal earthquakes in early 2015 which had devastating effects on healthcare service delivery system and population’s lifestyle .
Study design and tools
We conducted a cross sectional study to assess the QOL among patients living with T2DM in Nepal. We employed the WHOQOL-BREF, a shorter version of WHOQOL 100 survey tool, which was developed by the WHO to capture the broad aspects of health related QOL .Through field trials in many countries, WHOQOL-BREF has been validated as a standard tool to measure QOL cross culturally. In particular, we employed the Nepali version of WHO-BREF as used by Giri et al .This survey tool is a structured questionnaire consisting of 26 items in four domains, namely i) physical health, ii) psychological health, iii) social relationship, and iv) environment. Tables 1 and 2 summarizes the features of WHOQOL-BREF. Higher scores denote higher QOL. We also included nine additional Nepal specific socio-demographic variables in our questionnaire, namely history of diagnosis (time since diagnosis of diabetes as of the day of survey), current drinking (alcohol) status, smoking status, consumption of any tobacco product, depression, diabetes complications such as retinopathy, neuropathy, cardiac complications and nephropathy. The questionnaire and scoring methods on WHO-BREF are described elsewhere . We used Nepali version of Patient Health Questionnaire-9 (PHQ-9), a concise and self-administered tool for screening and diagnosis of depression. The tool has been well-validated with sufficient sensitivity and specificity for the diagnosis of major depression [20, 21]. The tool has nine items for recording frequency of symptoms of depression during the past 2 weeks. Table 2 summarizes the components of PHQ-9. The responses are recorded as ‘not at all’, ‘several days’, ‘more than half the days’ or ‘nearly every day’. Patients identified with major depression disorder were advised for further medical assistance. Nepali version of both the WHO-BREF and PHQ9 were pre-tested separately among 20 diabetes patients to test its accuracy before data collection. Based on pre-testing, we made minor changes in wording of the questions.
Diabetes is often accompanied by overweight and obesity, so measuring BMI and checking for overweight or obesity status can further help explore QOL in people with diabetes. Therefore we also conducted anthropometric measurement of the participants' height and weight. Height of the respondents was measured in standing position using portable stadiometer to the nearest centimeters. Weight was measured by using bathroom scale, calibrated at zero initially, which could detect a mass to nearest 0.1 kg. We measured the waist circumference at midway between the lowest rib and the iliac crest to the nearest 1 cm using a tailors’ (inch) tape. For each anthropometric measure, we took two readings for a given patient and the average values were considered as final.
Study setting and sample
Tribhuvan University Teaching Hospital (TUTH) is the largest tertiary hospital in Nepal. It is located in the metropolitan city of Kathmandu. Attended by thousands of patients daily, this hospital is a major source of affordable specialty care for people living in Kathmandu valley as well as those in distant rural areas of Nepal. Many people get tested for diabetes voluntarily, or are referred by other departments of TUTH. The hospital has one diabetes care clinic with several staff members that provides services including glycemic monitoring and counselling.
Based on the hospital informal statistics, an average of 30 people visited the diabetes clinic daily during the month of April 2014. Between July and September 2014, trained interviewers recruited every fifth patients visiting the clinic (i.e. approximately 6 people a day) and conducted face-to-face interviews at the clinic. We recruited 157 participants by the end of the study. Interviewers were trained in interviewing techniques and had been involved in similar research projects previously.
Definition of variables
The participant scores on the four domains of WHO-BREF (see Table 1) constituted the outcome variables. The scores on the 26-item questions were initially measured on a scale of 4–20 initially, and then these were converted to a scale of 100 in order to make the results comparable to any studies which employ the WHOQOL-100 questionnaire.
We collected the information about age, gender, ethnicity, education, occupation, marital status, monthly income (<10,000 NPR, 10,000–24,000 NPR, >24,000 NPR), residence (rural, urban), family history of diabetes (Yes, No), years since diagnosis (≤10 years, >10 years), use of any form of tobacco (Yes, No), current drinking (Yes, No), waist circumference (High if >90 cm, Low if ≤90 cm) and BMI (kg/m2) (<25, 25–30,>30). The respondents who resided at a Village Development Committee were classified as rural inhabitants whereas those residing in a municipality were classified as urban inhabitants. Having any diabetes complication was reported "yes” if respondents reported at least one of the complications i.e. cardiac complications, retinopathy, neuropathy and nephropathy. Diabetic complications were assessed by the interviewers on the basis of symptoms reported by the patients. PHQ-9 score was measured as a continuous variable initially; however it was also categorized into ‘no depression’ (0–4), ‘mild’ (5–9), ‘moderate’ (10–14) and ‘severe depression’ (≥ 15), which was further categorized into ‘no severe depression (<10)’and ‘severe depression (≥ 10)’ during regression analysis.
Another important factor affecting diabetes patients’ QOL is their compliance to the ongoing therapy, which we could estimate by measuring patients’ glycated haemoglobin (HbA1c) levels. However given the resource constraints to conduct this survey, we did not measure HbA1c levels.
We entered the collected data in EpiData 3.1 and then transferred the data to SPSS IBM 20 software for analysis. Descriptive statistics were presented as frequency, percentage, mean and median. Pearson’s correlation, chi-square test and analysis of variance (ANOVA) tests were used for categorical, discrete and continuous variables. Variables with p-value<0.10 (alpha significance level) were further analyzed using multivariate analysis using a stepwise backward elimination procedure.
To assess the internal consistency (i.e. the extent to which different domain items lead to consistent results) of the survey tool, we performed Cronbach alpha test. We also tested the correlation between individual domain scores.
We obtained ethical approval to conduct this study from the institutional review committee of Manmohan Memorial Institute of Health Sciences, Lalitpur, Nepal. The study objectives were clearly explained to the study participants prior to the data collection and their written consents were obtained. Respondents were informed about their right to not answer any questions or to withdraw at any time during the interview.
Demographic characteristics of study participants
Table 3 presents the participant's demographic characteristics. 60.5% of the participants were female, 41.4% were 45–59 years of age, 49.7% belonged to Brahmin/Chhetri ethnic group and 59.9% had completed 10 or less years of schooling. Nearly two third (65.6%) of the participants resided in urban areas, 51.6% were unemployed and 45.6% had monthly income of NPR 10,000–24,000 (100 NPR = 1 USD). More than two third of the respondents (77.1%) were living with diagnosed diabetes for 10 years or less. Few respondents were smokers (5.7%) or consumed alcohol (8.3%) or any form of tobacco products (12.7%). Nearly 40.1% of respondents had positive family history of diabetes. Over half (54.1%) of the respondents experienced depression: of which 30.6% of the respondents had mild depression and 8.3% were severely depressed. Regarding the co-morbidities, retinopathy (26.8%), neuropathy (32.5%), cardiac complications (14.6%) and nephropathy (1.3%) were present among the respondents.
Measurement properties of WHO-BREF
We found good internal consistency of the WHO-BREF questionnaire among the diabetes patient population. Cronbach’s alpha was 0.872 for the WHO-BREF questionnaire and was 0.756 between the individual domains scores (internal consistence), which is fairly higher than the usual standard of 0.7.Cronbach’s Alpha is the measurement of scale reliability. Higher value of it indicates higher internal consistency and vice versa. It is the function of number of test items and average inter item correlation. More on this with practical computing examples is explained elsewhere .The Pearson’s correlation coefficients between domain scores ranged from 0.327 to 0.827, thereby indicating a fairly good correlation overall. See Appendix for the correlation coefficients in four domains of WHO-BREF.
Factors associated with health-related QOL scores
Table 4 summarizes the domain-specific QOL scores among the study population. We found the highest mean (SD) score in social relationship domain (57.32 ± 8.94), followed by environment domain (54.71 ± 7.74), psychological health (53.25 ± 10.32) and physical health (50.74 ± 11.83). The Kolmogorov-Smimov normality test scores showed normal distribution in case of all domains and therefore we performed parametric hypothesis testing with the alpha significance level of 0.10. The findings from analysis of mean difference by covariates are shown in Table 5. BMI and waist circumference did not have any association with individual domain scores and overall QOL score. We found significant difference by residence status in physical health domain (p-value = 0.055), years since diabetes diagnosis in physical health domain (p-value = 0.068) and depression in social relationship domain (p-value = 0.031) and neuropathy in physical health (p-value = 0.019), and psychological health domain (p-value = 0.078).
Table 6 presents the result of multivariate linear regression analysis. After adjusting for other covariates, having urban residence decreased the physical health score by 4.74 scores (β = -4.74, 95% CI: -8.66, -0.82) and social relationship domain score by 3.42 scores (β = -3.42, 95% CI: -6.43, -0.41) and overall QOL by 2.77 scores (β = -2.77, 95% CI: -5.30, -0.25). Having diagnosed with diabetes since more than 10 years increased physical health by 5.18 scores (β = 5.18; 95% CI: 0.75, 9.62). Similarly, having severe depression decreased social relation domain score by 6.053 scores (β = -6.05, 95% CI: -11.17, -0.94).
To our knowledge, this is the first study to report QOL among people with T2DM in Nepal. We found the highest average QOL score in the social relationship domain. We infer that respondents maintained fairly good relationships with friends and relatives; received fairly good support from family, community and friends, and were satisfied with their sexual life. However, the QOL scores were lowest for physical health domain which indicates lowered energy and work capacity for daily living, higher dependence on medicinal substances and medical aids; fatigue, sleep-related problems, restlessness, reduced mobility, greater pain and discomfort in daily life.
Our analysis shows that after adjusting for other variables, having urban residence was associated with decreased QOL scores in physical health and social relationship domain scores by 4.74 and 3.42, respectively, and the overall QOL reduced by 2.77 scores. While an earlier study in Iran reported no rural-urban divide in QOL , the decreased QOL reported among urban dwellers in our study might be because more participants are of urban origin or this pattern could be specific to Nepalese population. Having diagnosed with diabetes since more than 10 years was associated with increase in physical health domain scores by 5.18. Contrarily, earlier study reported duration since diagnosis of T2DM had no effect in physical health domain, but negative correlation with social relationship domain was observed .We found that severe depression decreased social relationship domain scores by 6.05. This is in accordance with earlier studies which reported a negative association between depression symptoms and at least one aspect of QOL among the T2DM patients .
Although we didn’t find any effect of age and education on QOL, an earlier study from Turkey has shown that education is positively correlated with physical health, psychological health, social relationship, environment, and the overall QOL .The same study also reported a significant negative correlation between age and social relationship domain. Similarly, while we did not find any association of gender with QOL, a study among people with diabetic foot ulcers from Iran reported that men had an overall high QOL scores in all domains compared to the women .Furthermore, previous literature  suggest that lower QOL scores were associated with having minor diabetes-related complications. Also the effects of age, gender, metabolic activity, and education on overall QOL were found to be weak.
Our study has few strengths and limitations. This is the first study to assess QOL and depression among diabetes patients in Nepal. We used WHO-BREF which has been widely used across cultures and regions, and is a validated tool for measuring health-related QOL worldwide. Our study was limited to a single but major healthcare center in Nepal, and therefore our findings may not necessarily be generalizable to other populations in Nepal. Also, as mentioned earlier, we did not collect any data to assess the patients’ compliance to their ongoing therapy. Previous studies found high rates of non-compliance among the diabetes patients in Nepal , which is likely to have adverse effects on disease progression and could lower QOL .However some researchers also found that depression among diabetes patients is a major risk factor for non-compliance [10,11]. While we found co-existing lower QOL and depression among the diabetes patients, we are unable to assess the effect of non-compliance. Furthermore we report the QOL among the Nepalese T2DM population prior to the devastating 2015 Nepal earthquakes which we believe may have further increased depression levels. We recommend further studies to investigate the effects of depression and other diabetes-related comorbidities on QOL among larger T2DM populations.
We found that having urban residence significantly decreased physical health, social relation domain scores and overall QOL scores. Similarly, having diagnosed with diabetes since more than 10 years increased physical health domain score. We also found having severe depression significantly decreased the social relationship domain score, and might impede QOL on the whole. While literature suggests that people with diabetes have lower QOL in general, we found that depression among people with T2DM further reduced the QOL. Therefore, public health policy makers and program planners should focus on early diagnosis and prompt treatment of depression in people with diabetes as part of their routine primary care in Nepal.
We thank all the study participants for their time and information. We are grateful to the Department of Medicine, Maharajgunj Medical Campus and the staff members for their generous support during the study. We also thank Dipika Neupane, Sabita Thapa and Sarmila Dhakal for their support during data collection.
Conceived and designed the experiments: SRM. Performed the experiments: SRM PMB SB KT. Analyzed the data: SRM. Contributed reagents/materials/analysis tools: SRM PMD AS. Wrote the paper: SRM PMB AS SB KT.
- 1. Bloom DE, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of noncommunicable diseases. World Economic Forum, Harvard School of Public Health, 2012.
- 2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes care. 1998;21(9):1414–31. pmid:9727886
- 3. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. Jama. 2009;301(20):2129–40. pmid:19470990
- 4. World Health Organization. Prevalence of Diabetes in South East Asia Region 2010. Available from: http://www.who.int/diabetes/facts/world_figures/en/.
- 5. Baral N, Koner BC, Karki P, Ramaprasad C, Lamsal M, Koirala S. Evaluation of new WHO diagnostic criteria for diabetes on the prevalence of abnormal glucose tolerance in a heterogeneous Nepali population—the implications of measuring glycated hemoglobin. Singapore medical journal. 2000;41(6):264–7. pmid:11109341
- 6. Singh DL, Bhattarai MD. High prevalence of diabetes and impaired fasting glycaemia in urban Nepal. Diabetic Medicine. 2003;20(2):170–1. pmid:12581274
- 7. Chhetri MR, Chapman RS. Prevalence and determinants of diabetes among the elderly population in the Kathmandu Valley of Nepal. Nepal Med Coll J. 2009;11(1):34–8. Epub 2009/09/23. pmid:19769235
- 8. Kiadaliri AA, Najafi B, Mirmalek-Sani M. Quality of life in people with diabetes: a systematic review of studies in Iran. Journal of diabetes and metabolic disorders. 2013;12(1):54. pmid:24354933
- 9. Eren I, Erdi O, Sahin M. The effect of depression on quality of life of patients with type II diabetes mellitus. Depress Anxiety. 2008;25(2):98–106. pmid:Medline:17311266.
- 10. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Archives of internal medicine. 2000;160(14):2101–7. Epub 2000/07/25. pmid:10904452.
- 11. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes care. 2000;23(7):934–42. Epub 2000/07/15. pmid:10895843
- 12. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142 Suppl:S8–21. pmid:23062861
- 13. Thommasen HV, Berkowitz J, Thommasen AT, Michalos AC. Understanding relationships between diabetes mellitus and health-related quality of life in a rural community. Rural and remote health. 2005;5(3):441. pmid:16120021
- 14. Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and quality of life outcomes. 2010;8:18. Epub 2010/02/06. pmid:20132542
- 15. Grandy S, Fox KM. Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study. Health and quality of life outcomes. 2012;10:99. Epub 2012/08/25. pmid:22917219
- 16. Porojan M, Poanta L, Dumitrascu DL. Assessing health related quality of life in diabetic patients. Romanian journal of internal medicine = Revue roumaine de medecine interne. 2012;50(1):27–31. Epub 2012/07/14. pmid:22788091
- 17. Sharma A, Mishra SR. Secure sanitation and access to clean water in earthquake-struck Nepal. BMJ. 2015;2015(350):h2430.
- 18. World Health Organization. WHOQOL-BRIEF Introduction, Administration, Scoring and Generic Version of the Assessment WHOQOL-BRIEF 1996 [cited 2014 September 20]. Available from: http://www.who.int/mental_health/media/en/76.pdf.
- 19. Giri S, Neupane M, Pant S, Timalsina U, Koirala S, Timalsina S, et al. Quality of life among people living with acquired immune deficiency syndrome receiving anti-retroviral therapy: a study from Nepal. HIV AIDS (Auckl). 2013;5:277–82.
- 20. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. Jama. 1999;282(18):1737–44. pmid:10568646
- 21. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. Journal of general internal medicine. 2001;16(9):606–13. Epub 2001/09/15. pmid:11556941
- 22. Institute of Digital Research and Education, UCLA. SPSS FAQ: What does Cronbach's alpha mean? CA, USA: UCLA; [cited 2015 August 14]. Available from: http://www.ats.ucla.edu/stat/spss/faq/alpha.html.
- 23. Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Current diabetes reviews. 2009;5(2):112–9. pmid:19442096
- 24. Yekta Z, Pourali R, Ghasemi-Rad M. Comparison of demographic and clinical characteristics influencing health-related quality of life in patients with diabetic foot ulcers and those without foot ulcers. Diabetes Metab Syndr Obes. 2011;4:393–9. pmid:22253537
- 25. Wandell PE. Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scandinavian journal of primary health care. 2005;23(2):68–74. pmid:16036544
- 26. Shrestha SS, Shakya R, Karmacharya BM, Thapa P. Medication adherence to oral hypoglycemic agents among type II diabetic patients and their clinical outcomes with special reference to fasting blood glucose and glycosylated hemoglobin levels. Kathmandu Univ Med J (KUMJ). 2013;11(43):226–32. Epub 2014/01/21.
- 27. Chaveepojnkamjorn W, Pichainarong N, Schelp FP, Mahaweerawat U. Quality of life and compliance among type 2 diabetic patients. Southeast Asian J Trop Med Public Health. 2008;39(2):328–34. Epub 2008/06/21. pmid:18564722